225 related articles for article (PubMed ID: 28541260)
21. Clinicopathologic and gene expression analysis of initial biopsies from patients with eosinophilic esophagitis refractory to therapy.
Siddique AS; Corney DC; Mangray S; Lombardo KA; Chen S; Marwaha AS; Resnick MB; Herzlinger M; Matoso A
Hum Pathol; 2017 Oct; 68():79-86. PubMed ID: 28882697
[TBL] [Abstract][Full Text] [Related]
22. The management of eosinophilic esophagitis.
Greenhawt M; Aceves SS; Spergel JM; Rothenberg ME
J Allergy Clin Immunol Pract; 2013; 1(4):332-40; quiz 341-2. PubMed ID: 24565538
[TBL] [Abstract][Full Text] [Related]
23. Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients.
Wolf WA; Cotton CC; Green DJ; Hughes JT; Woosley JT; Shaheen NJ; Dellon ES
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):452-8. PubMed ID: 25086190
[TBL] [Abstract][Full Text] [Related]
24. One-year outcomes in children with eosinophilic esophagitis.
Kovačić M; Unić J; Mišak Z; Jadrešin O; Konjik V; Kolaček S; Hojsak I
Esophagus; 2019 Apr; 16(2):162-167. PubMed ID: 30341631
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and Treatment of Eosinophilic Esophagitis in Adults.
Kavitt RT; Hirano I; Vaezi MF
Am J Med; 2016 Sep; 129(9):924-34. PubMed ID: 27155108
[TBL] [Abstract][Full Text] [Related]
26. Eosinophilic oesophagitis.
Heine RG; Allen KJ
Chem Immunol Allergy; 2015; 101():199-208. PubMed ID: 26022880
[TBL] [Abstract][Full Text] [Related]
27. Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet.
Kagalwalla AF; Shah A; Li BU; Sentongo TA; Ritz S; Manuel-Rubio M; Jacques K; Wang D; Melin-Aldana H; Nelson SP
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):145-9. PubMed ID: 21788754
[TBL] [Abstract][Full Text] [Related]
28. Eosinophilic esophagitis: short and long-term considerations.
Goyal A
Curr Opin Pediatr; 2018 Oct; 30(5):646-652. PubMed ID: 30015687
[TBL] [Abstract][Full Text] [Related]
29. Eosinophilic Esophagitis: An Evidence-Based Approach to Therapy.
González-Cervera J; Lucendo AJ
J Investig Allergol Clin Immunol; 2016; 26(1):8-18; quiz 2p following 18. PubMed ID: 27012011
[TBL] [Abstract][Full Text] [Related]
30. Emerging therapies for eosinophilic esophagitis.
Greuter T; Hirano I; Dellon ES
J Allergy Clin Immunol; 2020 Jan; 145(1):38-45. PubMed ID: 31705907
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal Growth Outcomes Following First-line Treatment for Pediatric Patients With Eosinophilic Esophagitis.
Jensen ET; Huang KZ; Chen HX; Landes LE; McConnell KA; Almond MA; Safta AM; Johnston DT; Durban R; Jobe L; Frost C; Donnelly S; Antonio B; Quiros A; Markowitz JE; Dellon ES
J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):50-55. PubMed ID: 30074576
[TBL] [Abstract][Full Text] [Related]
32. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet.
Spergel JM; Brown-Whitehorn TF; Cianferoni A; Shuker M; Wang ML; Verma R; Liacouras CA
J Allergy Clin Immunol; 2012 Aug; 130(2):461-7.e5. PubMed ID: 22743304
[TBL] [Abstract][Full Text] [Related]
33. Serum eosinophil cationic protein is superior to mast cell tryptase as marker for response to topical corticosteroid therapy in eosinophilic esophagitis.
Schlag C; Pfefferkorn S; Brockow K; Haller B; Slotta-Huspenia J; Schulz S; von Werder A; Ring J; Schmid RM; Bajbouj M
J Clin Gastroenterol; 2014 Aug; 48(7):600-6. PubMed ID: 24177377
[TBL] [Abstract][Full Text] [Related]
34. Eosinophilic esophagitis: review of nonsurgical treatment modalities.
Reddy V; Ghaffari G
Allergy Asthma Proc; 2013; 34(5):421-6. PubMed ID: 23998238
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies.
Lucendo AJ
Expert Rev Clin Immunol; 2020 Jan; 16(1):63-77. PubMed ID: 31842634
[No Abstract] [Full Text] [Related]
36. Medical therapy versus dietary avoidance in eosinophilic esophagitis: Which approach is better?
Chehade M; Sher E
Allergy Asthma Proc; 2017 May; 38(3):170-176. PubMed ID: 28441986
[TBL] [Abstract][Full Text] [Related]
37. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
[TBL] [Abstract][Full Text] [Related]
38. Four-food group elimination diet for adult eosinophilic esophagitis: A prospective multicenter study.
Molina-Infante J; Arias A; Barrio J; Rodríguez-Sánchez J; Sanchez-Cazalilla M; Lucendo AJ
J Allergy Clin Immunol; 2014 Nov; 134(5):1093-9.e1. PubMed ID: 25174868
[TBL] [Abstract][Full Text] [Related]
39. Pathophysiological bases of eosinophilic esophagitis therapy.
Moreno-Borque R; Gisbert JP; Santander C
Inflamm Allergy Drug Targets; 2013 Feb; 12(1):46-53. PubMed ID: 23110509
[TBL] [Abstract][Full Text] [Related]
40. Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis.
Rubinstein E; Hait EE; Mitchell PD; Lee JJ
J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):395-397. PubMed ID: 28837508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
